Rhythm Pharmaceuticals (RYTM) Gross Margin Growth (1y) (2022 - 2026)

Rhythm Pharmaceuticals (RYTM) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -91.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 236.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 228.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -475.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1,034.00
10 Rhythm Pharmaceuticals 7.95 Bn 7.62 Bn 62.32 Mn -111.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -111.00
Mar 31, 2026 -75.00
Dec 31, 2025 67.00
Sep 30, 2025 79.00
Jun 30, 2025 -129.00
Mar 31, 2025 -34.00
Dec 31, 2024 429.00
Sep 30, 2024 -79.00
Jun 30, 2024 150.00
Mar 31, 2024 158.00
Dec 31, 2023 -2,611.00
Sep 30, 2023 88.00
Jun 30, 2023 -746.00
Mar 31, 2023 296.00
Dec 31, 2022 2,576.00
Sep 30, 2022 999.00
Jun 30, 2022 4,583.00
Mar 31, 2022 -393.00